Web interface to evaluate the cost-effectiveness of vaccination of infants in the Netherlands with the Pneumococcal Conjugate Vaccine (PCV)
Try out the interactive dashboard to use the economic model underlying this study.
Also, you can try out a more detailed webinterface to perform online customized scenario analysis.
Background
This website was published parallel with the publication [PubMed] on the cost-effectiveness of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands [Abstract], a study performed by University of Groningen, the Netherlands. On this website we provide tools that are publicly accessable tools that you can use to interact with the model that underlies this evaluation and perform custom scenario- and sensitivity analysis.
More information
You can read here a summary of background information on the Pneumococcal Conjugate Vaccine This study is a health economic cost-effectiveness analysis. Read a brief introduction to health economics.